SCHEMBL5236334

SCHEMBL5236334

CCc1ccccc1Nc1ccnc2sc(C(N)=O)c(N)c12

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.69
HTT P42858 4/20 0.69
KDM4E B2RXH2 2/20 0.69
HPGD P15428 2/20 0.69
ALOX15 P16050 2/20 0.69
TSHR P16473 2/20 0.69
MAPK1 P28482 1/20 0.69
HSD17B10 Q99714 1/20 0.69
IKBKB O14920 7/20 0.56
LIMK1 P53667 2/20 0.55
CDK8 P49336 7/20 0.52
CDK19 Q9BWU1 3/20 0.52
CHUK O15111 1/20 0.45
TP53 P04637 1/20 0.44
LMNA P02545 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
STAT1 P42224 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL427267 0.82 ALDH1A1 (1.00) ALDH1A1HTTKDM4EHPGDALOX15
SCHEMBL28763128 0.81 ALDH1A1 (0.68) ALDH1A1HTTKDM4EHPGDALOX15
SCHEMBL27702802 0.79 KDM4E (0.61) ALDH1A1HTTKDM4EHPGDALOX15
SCHEMBL5235050 0.79 IKBKB (0.61) ALDH1A1HTTKDM4EHPGDALOX15
SCHEMBL16071477 0.77 KDM4E (0.65) ALDH1A1HTTKDM4EHPGDALOX15
SCHEMBL5234057 0.77 ALDH1A1 (0.69) ALDH1A1HTTKDM4EHPGDALOX15
SCHEMBL5234359 0.75 ALDH1A1 (0.60) ALDH1A1HTTKDM4EHPGDALOX15
SCHEMBL5236613 0.75 ALDH1A1 (0.60) ALDH1A1HTTKDM4EHPGDALOX15
SCHEMBL27723170 0.75 ALDH1A1 (0.70) ALDH1A1HTTKDM4EHPGDALOX15
SCHEMBL27723169 0.75 IKBKB (0.57) ALDH1A1HTTKDM4EHPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070219234-A1 Thienopyridine Derivatives SANKYO COMPANY, LIMITED (JP) 2007-09-20 US disclosed
EP-1764367-A1 THIENOPYRIDINE DERIVATIVES Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219234-A1 Thienopyridine Derivatives RASGRP1, NRAS, HRH3 ALDH1A1 1073/4885HTT 3498/4885KDM4E 1851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.